Credits Available: 5.0 AMA PRA Category 1 Credits

Description: The proposed activities will inform clinicians of recent evidence from clinical trials on the efficacy and safety of TROP2-directed antibody-drug conjugates (ADCs) in patients with progressive NSCLC, allowing them to quickly integrate new treatments into their practice when they become available. Clinicians will be updated on HER2 genomic alterations and apply appropriate testing methodologies per the National Comprehensive Cancer Network (NCCN) guidelines for NSCLC. Furthermore, participants will receive education on the successful management of NSCLC, including managing brain metastases, optimal HER2-targeted ADC dosing, and monitoring approaches for treatment-related adverse events (AEs). Finally, the proposed activities aim to educate participants on the importance of targeting HER3 and using HER3-directed ADCs in the management of NSCLC. The initiative will also provide information on the efficacy and safety of these ADCs based on clinical trial data, as well as strategies for recognizing and minimizing treatment-related AEs to enhance therapy adherence and improve patient outcomes.

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:

Register

Step 1 of 3

This program is intended for:
Target Professions: DO, MD, Nurse Practitioner, Physician Assistant
Target Specialties: Oncology

Sivraj Muralikrishnan

Rutgers Cancer Institute of New Jersey
Assistant Professor of Medicine at Rutgers Robert Wood Johnson Medical School

I am currently an assistant professor of medicine at Rutgers Robert Wood Johnson Medical School in New Jersey with a clinical practice focused on thoracic, head & neck medical oncology. Prior to this, I was an assistant professor of medicine at Geisel School of Medicine Dartmouth, where my practice was focused on general hematology and medical oncology. I completed my fellowship training at Dartmouth Hitchcock Medical Center in New Hampshire and served as the associate program director of the Hematology/Oncology fellowship program this past year. I'm interested in medical education and teaching. I hope to foster a learning environment that is collaborative and engaging so that we may all learn from one another.